Natural-Cycle FET Guide: What If You Miss the LH Surge?

By Seungjoo Lee · Evidence guide · Updated October 5, 2026

Natural-cycle frozen embryo transfer (FET) can sound simple: wait for ovulation, then transfer. In practice, matching embryo development with the uterine lining involves monitoring, hormone interpretation and a clinic-specific schedule. This guide compares natural and programmed FET, explains LH surge and progesterone monitoring, and addresses the unsettling question: “What if I missed the surge?”

Start here: Natural does not mean unmonitored or necessarily medication-free. A missed home-test peak does not settle whether a transfer should proceed. The clinic needs to interpret the cycle.

In this guide: Cycle options · Success and safety evidence · Ovulation monitoring · Missed LH surge · Questions for your clinic

Natural, modified natural and programmed FET: what changes?

Approach	How the cycle is organized	What to clarify
True natural	Tracks spontaneous ovulation and the resulting corpus luteum.	Monitoring days, the timing marker and any progesterone support.
Modified natural	Uses an ovulation trigger in a monitored follicular cycle.	Trigger instructions and what happens if an LH rise has already started.
Programmed / hormone replacement	Uses prescribed estrogen and progesterone to prepare the lining without relying on spontaneous ovulation.	Medication start times, duration and the response to an unexpected hormone or scan result.

“Medicated” can be an imprecise label: a natural-cycle protocol may still include a trigger or progesterone support. Ask for the actual protocol name and written instructions. Regular ovulation, prior treatment history, access to monitoring and scheduling needs all belong in the conversation. Read our comparison of natural and programmed frozen embryo transfer.

Does a natural cycle improve the chance of a baby?

A 2026 multicenter randomized trial by Wei and colleagues enrolled 4,376 ovulatory women aged 20–40. Healthy live birth occurred in 41.6% assigned to natural ovulation and 40.6% assigned to programmed preparation: a 1.0-percentage-point difference, with a 95% confidence interval from −1.9 to 3.9. The study did not detect a significant difference in that outcome.

Among participants with a clinical pregnancy, pre-eclampsia occurred in 2.9% versus 4.6%, respectively. Those percentages use pregnant participants as the denominator; they are not the same population used for the healthy-live-birth calculation. Read the BMJ trial, DOI 10.1136/bmj-2025-087045.

This supports discussing pregnancy safety alongside transfer success. It does not establish one protocol for every patient, particularly people who do not ovulate regularly or fall outside the trial population. Nor does a nonsignificant difference prove that two treatments are identical.

How do clinics work out when ovulation happened?

LH rises before ovulation, while progesterone provides information about the transition toward the luteal phase. Ultrasound contributes information about follicular development and changes around ovulation. These observations answer related questions; they are not interchangeable timestamps.

The practical issue is coordination: the clinic must match its interpretation of the cycle with the embryo’s developmental stage and its own transfer protocol. A calendar prediction or two lines on a urine strip cannot, by itself, settle the transfer date. Our article on progesterone rise versus LH surge monitoring explains why a laboratory threshold should not become a home scheduling rule.

Missed the LH surge: is the cycle lost?

Not necessarily—but “not necessarily” is not permission to choose a transfer day yourself. Contact the clinic with the timing of your tests and any prescribed medication. Ask whether further hormone measurements or ultrasound can clarify the cycle, and what level of uncertainty would lead the team to defer transfer.

A prospective cohort from a Turkish IVF center compared 490 true natural FET cycles. Live birth occurred in 162/286 progesterone-timed cycles (56.6%) and 106/204 LH-timed cycles (52.0%). The adjusted relative risk was 1.09 (95% CI 0.93–1.30), with no statistically significant association between timing strategy and live birth. Aydin et al., Human Reproduction, 2026.

The timing strategy was not randomized. Monitoring included serial ultrasound and blood tests, and laboratory thresholds came from one center. The study does not prove equivalence, guarantee rescue of every missed surge, or show that home testing alone is enough. Read the missed-LH-surge study in more detail.

Why there is no universal “LH plus X days” instruction here

Patients may hear different day counts from different clinics. Before comparing them, ask what “day zero” means: the onset of a surge, a threshold blood result, a trigger injection, confirmed ovulation or progesterone exposure. A number without its reference point is easy to misread.

Keep the clinic’s written schedule in one place. If a dose was late, a test result changed or instructions conflict, contact the team before changing the plan. This guide intentionally does not supply a drug dose, hormone cutoff or replacement transfer schedule.

Questions to ask before starting a natural-cycle FET

Am I expected to ovulate reliably, and why does this protocol fit my history?
Which blood tests and scans determine the transfer date in your clinic?
Do I need home LH tests, and when should I report a result?
What is the plan if the surge happens overnight, over a weekend or between appointments?
Will I use a trigger or progesterone support, and where are the exact instructions?
What findings would make you postpone the transfer?
How do you balance live birth, pregnancy complications, monitoring burden and cost for me?

If this transfer follows previous failures, our recurrent implantation failure guide helps separate the question of cycle timing from the question of whether further investigation is justified.

Evidence behind this guide

Wei et al., PnROVE Study Group, 2026: BMJ 392:e087045. Multicenter randomized trial, 4,376 ovulatory women; research team includes Shandong University and collaborating centers.
Aydin et al., 2026: Human Reproduction 41(9):1581–1590. Single-center prospective cohort, 490 cycles; affiliations include Acibadem Mehmet Ali Aydinlar University and Acibadem Atakent Hospital, Istanbul. Observational results need external validation.

This guide provides fertility journalism and educational information, not an individual diagnosis or treatment plan. Discuss decisions with your fertility specialist. The featured illustration is AI-generated and does not depict a real patient or a diagnostic finding.